SW403 人結(jié)腸癌細(xì)胞
Catalogue No.: C1497
Product Format: a T25 flask
Culture Properties：貼壁
Complete Growth Medium: 89%L15+10%FBS+1%雙抗
Atmosphere: air, 99%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.

Components

1 (PD-1), which greatly enriches the choice of tumor immunotherapy. Related immune checkpoint inhibitors including CTLA4 inhibitors such as ipilimumab and tremelimumab, PD-1/programmed death 1 ligａnd 1 (PD-L1) inhibitors such as nivolumab, pembrolizumab and atezolizumab have been prepared and applied in the therapy of solid tumors such as melanoma, non-small cell lung cancer, digestive tract tumors and so on, which have get a